From the Department of Pediatric Infectious Diseases, Emma Children's Hospital, Academic Medical Centre (AMC), Amsterdam, The Netherlands.
Department of Medical Microbiology, AMC, Amsterdam, the Netherlands.
Pediatr Infect Dis J. 2020 Apr;39(4):267-272. doi: 10.1097/INF.0000000000002551.
Limited data are available on childhood encephalitis. Our study aimed to increase insight on clinical presentation, etiology, and clinical outcome of children with severe encephalitis in the Netherlands.
We identified patients through the Dutch Pediatric Intensive Care Evaluation database and included children diagnosed with encephalitis <18 years of age admitted to 1 of the 8 pediatric intensive care units (PICU) in the Netherlands between January 2003 and December 2013. We analyzed demographic characteristics, clinical symptoms, neurologic imaging, etiology, treatment and mortality.
We included 121 children with a median age of 4.6 years (IQR 1.3-9.8). The most frequently described clinical features were headache (82.1%), decreased consciousness (79.8%) and seizures (69.8%). In 44.6% of the children, no causative agent was identified. Viral- and immune-mediated encephalitis were diagnosed in 33.1% and 10.7% of the patients. A herpes simplex virus infection (13.2%) was mainly seen in children <5 years of age, median age, 1.73 years (IQR 0.77-5.01), while immune-mediated encephalitis mostly affected older children, median age of 10.4 years (IQR, 3.72-14.18). An age of ≥ 5 years at initial presentation was associated with a lower mortality (OR 0.2 [CI 0.08-0.78]). The detection of a bacterial (OR 9.4 [CI 2.18-40.46]) or viral (OR 3.7 [CI 1.16-11.73]) pathogen was associated with a higher mortality.
In almost half of the Dutch children presenting with severe encephalitis, a causative pathogen could not be identified, underlining the need for enhancement of microbiologic diagnostics. The detection of a bacterial or viral pathogen was associated with a higher mortality.
关于儿童脑炎的数据有限。我们的研究旨在增加对荷兰严重脑炎患儿临床表现、病因和临床转归的了解。
我们通过荷兰儿科重症监护评估数据库识别患者,并纳入 2003 年 1 月至 2013 年 12 月期间在荷兰 8 家儿科重症监护病房(PICU)之一入院的年龄<18 岁、诊断为脑炎的儿童。我们分析了人口统计学特征、临床症状、神经影像学、病因、治疗和死亡率。
我们纳入了 121 名年龄中位数为 4.6 岁(IQR 1.3-9.8)的儿童。最常描述的临床特征是头痛(82.1%)、意识下降(79.8%)和癫痫发作(69.8%)。在 44.6%的患儿中,未确定病因。病毒性和免疫介导性脑炎分别诊断为 33.1%和 10.7%的患者。单纯疱疹病毒感染(13.2%)主要见于<5 岁儿童,年龄中位数为 1.73 岁(IQR 0.77-5.01),而免疫介导性脑炎主要影响年龄较大的儿童,年龄中位数为 10.4 岁(IQR 3.72-14.18)。发病时年龄≥5 岁与死亡率降低相关(OR 0.2 [CI 0.08-0.78])。检测到细菌(OR 9.4 [CI 2.18-40.46])或病毒(OR 3.7 [CI 1.16-11.73])病原体与死亡率升高相关。
在荷兰近一半出现严重脑炎的儿童中,无法确定病因,这突显了需要增强微生物诊断。检测到细菌或病毒病原体与死亡率升高相关。